☰

Kristen Jacobsen - Publications

Affiliations: 
Immunology University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Lee-Sherick AB, Jacobsen KM, Henry CJ, Huey MG, Parker RE, Page LS, Hill AA, Wang X, Frye SV, Earp HS, Jordan CT, DeRyckere D, Graham DK. MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity. Jci Insight. 5. PMID 33268596 DOI: 10.1172/jci.insight.145847  0.49
2018 Lee-Sherick AB, Jacobsen KM, Henry CJ, Huey MG, Parker RE, Page LS, Hill AA, Wang X, Frye SV, Earp HS, Jordan CT, DeRyckere D, Graham DK. MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity. Jci Insight. 3. PMID 30385715 DOI: 10.1172/Jci.Insight.97941  0.586
2018 Lee-Sherick A, Jacobsen K, Henry CJ, Parker R, Wang X, Frye SV, Earp HS, DeRyckere D, Graham DK. Mertk Inhibition Promotes Anti-Leukemia Immunity By Reversing T Cell Suppression Via the PD-1 Axis Blood. 132: 4019-4019. DOI: 10.1182/Blood-2018-99-119818  0.514
2016 DeRyckere D, Lee Sherick AB, Huey MG, Hill AA, Tyner JW, Jacobsen KM, Page LS, Kirkpatrick GD, Eryildiz F, Montgomery SA, Zhang W, Wang X, Frye SV, Earp HS, Graham DK. UNC2025, a MerTK small molecule inhibitor, is therapeutically effective alone and in combination with methotrexate in leukemia models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27649555 DOI: 10.1158/1078-0432.Ccr-16-1330  0.528
2013 Cook RS, Jacobsen KM, Wofford AM, DeRyckere D, Stanford J, Prieto AL, Redente E, Sandahl M, Hunter DM, Strunk KE, Graham DK, Earp HS. MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis. The Journal of Clinical Investigation. 123: 3231-42. PMID 23867499 DOI: 10.1172/Jci67655  0.483
2013 Linger RM, Lee-Sherick AB, DeRyckere D, Cohen RA, Jacobsen KM, McGranahan A, Brandão LN, Winges A, Sawczyn KK, Liang X, Keating AK, Tan AC, Earp HS, Graham DK. Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia. Blood. 122: 1599-609. PMID 23861246 DOI: 10.1182/Blood-2013-01-478156  0.548
2011 Jacobsen K, Linger R, Graham D. TYRO3 (TYRO3 protein tyrosine kinase) Atlas of Genetics and Cytogenetics in Oncology and Haematology. DOI: 10.4267/2042/44892  0.473
2009 Linger RM, DeRyckere D, Brandão L, Sawczyn KK, Jacobsen KM, Liang X, Keating AK, Graham DK. Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia. Blood. 114: 2678-87. PMID 19643988 DOI: 10.1182/Blood-2009-03-209247  0.553
Show low-probability matches.